Skip to main content
OpenTrials
Completed

NCT Number: NCT02863861

Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients

The purpose of this study is to compere between Propofol-Ketamine combination and Dexmedetomidine-Ketamine combination for sedation in upper gastrointestinal endoscopy in paediatric patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Upper Gastrointestinal Endoscopy

Age range

2 year–7 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Ain shams university- faculty of medicine- department of anesthesia, intensive care and pain management

Cairo, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists ASA I-II patients aging 2-7 years.

Exclusion criteria

known allergy to any of the study drugs, significant cardiovascular disease vomiting.

Treatment and study plan

Dexmedetomidine-ketamine

Drug

propofol-ketamine

Drug

Primary outcomes

  1. length of stay in PACU

    Time frame: three months

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Comparative Study Between Propofol-Ketamine Combination and Dexmedetomidine-Ketamine Combination for Sedation in Upper Gastrointestinal Endoscopy in Paediatric Patients.

Important dates

Study start
2016
Primary completion
2016
First posted
Aug 11, 2016
Registry last updated
Dec 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.